Pelvic Radiation Disease Association
@pelvic_radiation_disease_association
UKhttp://prda.org.uk Hospitals and Health CareOverview
About Pelvic Radiation Disease Association
Pelvic Radiation Disease (PRD) is a long-term side-effect (‘late effect’) of pelvic radiotherapy treatment affecting an estimated 100,000 people in the UK.  People affected by PRD often have a complex set of symptoms affecting the bowel, bladder and/or sexual function for many years after radiotherapy, sometimes only appearing several years after radiotherapy treatment.
PRDA is a small UK charity whose Vision is:
That the long term effects of pelvic radiotherapy are prevented, predicted or minimised;
That people affected by Pelvic Radiation Disease (PRD) are diagnosed, fully supported and given the best possible care and treatment to alleviate their symptoms and improve their quality of life;
That Pelvic Radiation Disease is widely accepted as a serious consequence of cancer treatment that requires focused research and education.
PRDA aims to have an impact by:
Providing and facilitating direct support and information to people affected by, or at risk of, pelvic radiation disease (PRD);
Providing a voice for people affected by PRD;
Influencing decision-makers to achieve adequate, dedicated funding for PRD services across the UK including the adoption of a treatment tariff by NHS England;
Working with charity, professional organisations, NHS and other partners to improve health and social services for people affected by PRD;
Working with charity and professional organisation partners to improve professional awareness and education on the prevention and treatment of PRD.
PRDA is a small UK charity whose Vision is:
That the long term effects of pelvic radiotherapy are prevented, predicted or minimised;
That people affected by Pelvic Radiation Disease (PRD) are diagnosed, fully supported and given the best possible care and treatment to alleviate their symptoms and improve their quality of life;
That Pelvic Radiation Disease is widely accepted as a serious consequence of cancer treatment that requires focused research and education.
PRDA aims to have an impact by:
Providing and facilitating direct support and information to people affected by, or at risk of, pelvic radiation disease (PRD);
Providing a voice for people affected by PRD;
Influencing decision-makers to achieve adequate, dedicated funding for PRD services across the UK including the adoption of a treatment tariff by NHS England;
Working with charity, professional organisations, NHS and other partners to improve health and social services for people affected by PRD;
Working with charity and professional organisation partners to improve professional awareness and education on the prevention and treatment of PRD.